stockrowAurora Cannabis Inc. (ACB) vs Lifecore Biomedical, Inc. (LFCR)
- Aurora Cannabis Inc. ACB 5.23 +0.77%
- Lifecore Biomedical, Inc. LFCR 6.37 −0.47%
Aurora Cannabis Inc. and Lifecore Biomedical, Inc. are both Drug Manufacturers Specialty & Generic companies. Aurora Cannabis Inc. is the larger, with a market value of $341.2M against $242.6M — 1.4× the size. Aurora Cannabis Inc. grew revenue faster over the last twelve months: −18.2% against −18.2%. Aurora Cannabis Inc. has the higher net margin (−38.1% vs −65.9%) and the lower return on invested capital (−5.58% vs −2.14%). Across the 17 metrics below, Aurora Cannabis Inc. leads on 9 and Lifecore Biomedical, Inc. on 8.
Valuation
Profitability
| Metric | ACB | LFCR | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 49.74% | 27.38% | 53.51% |
| Operating margin | (12.13%) | (5.33%) | 0.00% |
| Net margin | (38.12%) | (65.91%) | (2.31%) |
| Free cash flow margin | (17.19%) | 18.13% | 0.00% |
| Return on equity | (19.85%) | 178.69% | (0.80%) |
| Return on assets | (15.19%) | (32.36%) | (1.67%) |
| Return on invested capital | (5.58%) | (2.14%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack